Health Care: Drugs

United Therapeutics Corp (UTHR: NASDAQ)

$133.82 0.26 | 0.19%
12/22/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 133.56
52 Week High 137.84
52 Week Low 84.63
Avg. Daily Vol. (Mil) 0.78
Beta (3 year) 1.30
Share Related Items
Mkt Cap (Mil) 6,345.29
Shares Out (Mil) 47.51
Float (Mil) 36.05
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.20
Current Ratio 1.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.25
Valuation Ratios
Price Earnings 39.60
Price/Sales 5.15
Price/Book 5.38
Price/Cash Flow 26.00
Per Share Data
Earnings 3.38
Sales 25.91
Book Value 24.85
Cash Flow 5.13
Business Summary
United Therapeutics Corp is a biotechnology company, which is focused on the development and commercialization of products to address the medical needs of patients with chronic and life-threatening conditions.
General Information
1040 Spring Street
Silver Spring, MD 20910
www.unither.com
Industry : Drugs
Sector: Health Care
Employees: 706
CEO: Martine A. Rothblatt,PhD
Short Interest
Current Month (Mil) 4.60
Previous Month (Mil) 4.86
Short Interest Ratio (Days) 6.40
Management Effectiveness
Return on Equity 16.40
Return on Assets 9.40
Return on Investments 16.40
Profitability
Gross Margin 92.00
EBIT Margin 27.40
Profit Margin 15.70

Portfolios with UTHR

Latest UTHR Headlines from TheStreet

More Financial News for UTHR

Press Releases for UTHR

See All Press Releases

Partner Headlines for UTHR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter